BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26219896)

  • 1. Transforming acidic coiled-coil-containing protein 3 (TACC3) overexpression in hepatocellular carcinomas is associated with "stemness" and epithelial-mesenchymal transition-related marker expression and a poor prognosis.
    Nahm JH; Kim H; Lee H; Cho JY; Choi YR; Yoon YS; Han HS; Park YN
    Tumour Biol; 2016 Jan; 37(1):393-403. PubMed ID: 26219896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.
    Kim H; Choi GH; Na DC; Ahn EY; Kim GI; Lee JE; Cho JY; Yoo JE; Choi JS; Park YN
    Hepatology; 2011 Nov; 54(5):1707-17. PubMed ID: 22045674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing "stemness"-related markers.
    Kim H; Yoo JE; Cho JY; Oh BK; Yoon YS; Han HS; Lee HS; Jang JJ; Jeong SH; Kim JW; Park YN
    J Hepatol; 2013 Oct; 59(4):746-52. PubMed ID: 23685049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Clinicopathological Significance of YAP/TAZ Expression in Hepatocellular Carcinoma with Relation to Hypoxia and Stemness.
    Park H; Lee Y; Lee K; Lee H; Yoo JE; Ahn S; Park YN; Kim H
    Pathol Oncol Res; 2021; 27():604600. PubMed ID: 34257565
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatocellular carcinomas expressing 'stemness'-related markers: clinicopathological characteristics.
    Kim H; Park YN
    Dig Dis; 2014; 32(6):778-85. PubMed ID: 25376296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of Yes-associated protein 1 in hepatocellular carcinoma with stemness and combined hepatocellular-cholangiocarcinoma.
    Kim GJ; Kim H; Park YN
    PLoS One; 2013; 8(9):e75449. PubMed ID: 24086533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma.
    Zhou DS; Wang HB; Zhou ZG; Zhang YJ; Zhong Q; Xu L; Huang YH; Yeung SC; Chen MS; Zeng MS
    Oncotarget; 2015 Sep; 6(27):24163-77. PubMed ID: 26219398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma-smooth muscle actin expression is associated with epithelial-mesenchymal transition and stem-like properties in hepatocellular carcinoma.
    Benzoubir N; Mussini C; Lejamtel C; Dos Santos A; Guillaume C; Desterke C; Samuel D; Bréchot C; Bourgeade MF; Guettier C
    PLoS One; 2015; 10(6):e0130559. PubMed ID: 26110787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis.
    Huang ZL; Lin ZR; Xiao YR; Cao X; Zhu LC; Zeng MS; Zhong Q; Wen ZS
    Oncotarget; 2015 Mar; 6(9):6850-61. PubMed ID: 25760075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SALL4 Expression in Hepatocellular Carcinomas Is Associated with EpCAM-Positivity and a Poor Prognosis.
    Park H; Lee H; Seo AN; Cho JY; Choi YR; Yoon YS; Han HS; Park YN; Kim H
    J Pathol Transl Med; 2015 Sep; 49(5):373-81. PubMed ID: 26265684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratin 19: a key role player in the invasion of human hepatocellular carcinomas.
    Govaere O; Komuta M; Berkers J; Spee B; Janssen C; de Luca F; Katoonizadeh A; Wouters J; van Kempen LC; Durnez A; Verslype C; De Kock J; Rogiers V; van Grunsven LA; Topal B; Pirenne J; Vankelecom H; Nevens F; van den Oord J; Pinzani M; Roskams T
    Gut; 2014 Apr; 63(4):674-85. PubMed ID: 23958557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keratin 19, a Cancer Stem Cell Marker in Human Hepatocellular Carcinoma.
    Kawai T; Yasuchika K; Ishii T; Katayama H; Yoshitoshi EY; Ogiso S; Kita S; Yasuda K; Fukumitsu K; Mizumoto M; Hatano E; Uemoto S
    Clin Cancer Res; 2015 Jul; 21(13):3081-91. PubMed ID: 25820415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Clinicopathological and Prognostic Significance of Nrf2 and Keap1 Expression in Hepatocellular Carcinoma.
    Lee K; Kim S; Lee Y; Lee H; Lee Y; Park H; Nahm JH; Ahn S; Yu SJ; Lee K; Kim H
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Associations between interleukin-17A expression and epithelial-mesenchymal transition in patients with hepatocellular carcinoma].
    Xu J; Wang J; Hu Y; Cheng L; Yu H
    Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):585-90. PubMed ID: 26714598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of stemness markers (CD133 and EpCAM) in prognostication of hepatocellular carcinoma.
    Chan AW; Tong JH; Chan SL; Lai PB; To KF
    Histopathology; 2014 Jun; 64(7):935-50. PubMed ID: 24506513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour epithelial and stromal characteristics of hepatocellular carcinomas with abundant fibrous stroma: fibrolamellar versus scirrhous hepatocellular carcinoma.
    Kim YJ; Rhee H; Yoo JE; Alves VAF; Kim GJ; Kim HM; Herman P; Chagas A; Kim H; Park YN
    Histopathology; 2017 Aug; 71(2):217-226. PubMed ID: 28326574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo HAPLN1 expression hallmarks Wnt-induced stem cell and fibrogenic networks leading to aggressive human hepatocellular carcinomas.
    Mebarki S; Désert R; Sulpice L; Sicard M; Desille M; Canal F; Dubois-Pot Schneider H; Bergeat D; Turlin B; Bellaud P; Lavergne E; Le Guével R; Corlu A; Perret C; Coulouarn C; Clément B; Musso O
    Oncotarget; 2016 Jun; 7(26):39026-39043. PubMed ID: 27191501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.
    Yamashita T; Forgues M; Wang W; Kim JW; Ye Q; Jia H; Budhu A; Zanetti KA; Chen Y; Qin LX; Tang ZY; Wang XW
    Cancer Res; 2008 Mar; 68(5):1451-61. PubMed ID: 18316609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma.
    Yamada S; Okumura N; Wei L; Fuchs BC; Fujii T; Sugimoto H; Nomoto S; Takeda S; Tanabe KK; Kodera Y
    Ann Surg Oncol; 2014 Nov; 21(12):3882-90. PubMed ID: 24833103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinico-Radio-Pathological and Molecular Features of Hepatocellular Carcinomas with Keratin 19 Expression.
    Rhee H; Kim H; Park YN
    Liver Cancer; 2020 Dec; 9(6):663-681. PubMed ID: 33442539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.